Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Robert Hatfield

Urology Brentwood, TN Medical Doctor

NPI 1104826163 CMS profile 231065

828 Old Hickory Blvd, Suite 502, Brentwood, TN 37027

Open in the dashboard

General payments

$2,469

97 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Robert Hatfield of Brentwood, TN is reported in the CMS Open Payments database as having received $2,469 across 97 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 48th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $154 7
2022 General $1,269 54
2021 General $583 22
2020 General $79 4
2019 General $383 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Hatfield
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Robert Hatfield were reported at $0. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Robert Hatfield Urology median Middle half National median
2019 $383 $480 $147–$1,201 $163
2020 $79 $246 $87–$645 $114
2021 $583 $358 $111–$1,000 $132
2022 $1,269 $476 $143–$1,263 $149
2023 $154 $560 $168–$1,461 $160
2024 $0 $563 $170–$1,464 $164
2025 $0 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Teleflex LLC $690 14 payments
  2. Urovant Sciences Inc $464 20 payments
  3. NeoTract Inc. $239 10 payments
  4. Axonics Modulation Technologies, Inc. $192 12 payments
  5. TOLMAR Pharmaceuticals, Inc. $189 10 payments
  6. Covidien LP $146 1 payment
  7. Astellas Pharma US Inc $130 8 payments
  8. Rochester Medical Corporation $92 5 payments
  9. Sumitomo Pharma America, Inc. $57 2 payments
  10. Coloplast Corp $51 1 payment
  11. Other $219 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $2,469 97 payments
Products named General payments · program years 2019–2023
  1. GEMTESA $521 22 payments
  2. UROLIFT $460 15 payments
  3. ELIGARD $208 11 payments
  4. UroLift System Interventional Urology $176 4 payments
  5. UroLift System Interventional Urology $154 3 payments
  6. LigaSure $146 1 payment
  7. UroLift ATC System $140 2 payments
  8. MYRBETRIQ $130 8 payments
  9. Bulkamid $99 3 payments
  10. XTANDI $59 4 payments
  11. Other $453 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Urology: 1,053

Drug cost

$227

Median for Urology: $101,464

Branded share of claims

0%

Median for Urology: 27.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Finasteride Generic 13 $227

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.

Records

97 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record